Tag:
Biomet
Latest Headlines
Latest Headlines
Biomet looks to score DePuy's trauma biz for $280M
The merger and acquisition trend in the device arena seems to be carrying over from 2011. Biomet has made a binding offer to acquire the worldwide trauma business of DePuy Orthopaedics for about $280 million.
Biomet to cough up almost $23M to settle bribery charges
Another devicemaker has been ensnared in a Foreign Corrupt Practices Act probe.
S&N takeover rumors rekindled
Smith & Nephew is back in the news as a potential takeover target with Biomet and Stryker ( $SYK ) named as suitors. Warsaw, IN-based Biomet is rumored to be planning an £8 billion ($13
FDA clears Biomet hip system
Biomet has received the FDA's OK to sell its Active Articulation E1 dual mobility hip system. The company says it is the first hip system in the U.S. to merge the concept of dual mobility with the
Biomet announces Q3 results
Biomet has posted soft replacement-joint sales in its Q3 2011 report. And as MarketWatch points out, this could raise new questions about an orthopedics market, which has been hurt by the global
Host of bidders in race for AstraZeneca dental unit
Zimmer Holdings and Biomet are among the bidders for AstraZeneca's Astra Tech, a Swedish unit that makes dental implants and medical devices, sources told Bloomberg. Report
S&N: We're not in merger talks
Smith & Nephew Friday tried to put a stop to rumors that it was in merger talks following a report it was considering a deal with rival Biomet. That report had sent the company's stock higher, as
Biomet receives warning letter, gets tax abatement approved
Biomet has received a warning letter from the FDA regarding its Signature personalized patient care system, a pre-operative surgical planning offering for knee replacement procedures. The agency
Biomet investing $26M, creating 280 jobs
Biomet, a Warsaw, IN-based orthopedics manufacturer, will expand its facilities in a $26 million effort that could create up to 280 jobs and move some of their production from New Jersey to the
